Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection
Clinical trial NCT02664415 · COMPLETED
Trial details
- NCT number
- NCT02664415
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-08-04
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.